AIDS Treatment Data Network
611 Broadway, Suite 613, New York, NY, 10012 • www.atdn.org • Tel: (212) 260-8868 • (NYS) 800-734-7104
The Access Project collects and distributes information about medications available for HIV/AIDS and hepatitis co-infection through Medicaid, Medicare Part D, AIDS Drug Assistance Programs (ADAPs), and pharmaceutical industry sponsored patient assistance and expanded access programs (EAP). The Access Project is a program of the The Network (network@atdn.org)

Aventis
Patient Assistance Program

Product covered:

Rifampin (rifadin) 1-800-221-4025




Contact
Program Eligibility
The patient must meet the following criteria to qualify:
  • Must be a U.S. Citizen.
  • Has no health insurance or no prescription coverage.
  • Not eligible for Medicaid, ADAP, or other drug assistance programs.
  • Income must be lower than 200% of the Federal Poverty Level.
Enrollment Process
Doctors or patients can call to enroll. An application is then sent to the doctor's office for completion.
Re-Application
Patients must be re-enrolled every three months.
Comments
The processing will take from 3-4 weeks to be completed and the drug to be sent tohe doctor's office.

About The Network - Donate - About The Access Project
Last modified: 11/16/2007
© 2007 The Network